Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles
Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles
复制标题
DOI:
10.1096/fj.201902354r
复制
发表时间:
2020-02-01
期刊:
影响因子:
4.8
通讯作者:
Leof, Edward B.
中科院分区:
文献类型:
--
作者:
Kang, Jeong-Han;Jung, Mi-Yeon;Leof, Edward B.
Transforming growth factor-beta (TGF beta) is an enigmatic protein with various roles in healthy tissue homeostasis/development as well as the development or progression of cancer, wound healing, fibrotic disorders, and immune modulation, to name a few. As TGF beta is causal to various fibroproliferative disorders featuring localized or systemic tissue/organ fibrosis as well as the activated stroma observed in various malignancies, characterizing the pathways and players mediating its action is fundamental. In the current study, we found that TGF beta induces the expression of the immunoinhibitory molecule Programed death-ligand 1 (PD-L1) in human and murine fibroblasts in a Smad2/3- and YAP/TAZ-dependent manner. Furthermore, PD-L1 knockdown decreased the TGF beta-dependent induction of extracellular matrix proteins, including collagen I alpha 1 (colI alpha 1) and alpha-smooth muscle actin (alpha-SMA), and cell migration/wound healing. In addition to an endogenous role for PD-L1 in profibrotic TGF beta signaling, TGF beta stimulated-human lung fibroblast-derived PD-L1 into extracellular vesicles (EVs) capable of inhibiting T cell proliferation in response to T cell receptor stimulation and mediating fibroblast cell migration. These findings provide new insights and potential targets for a variety of fibrotic and malignant diseases.